ENKEPHALINERGIC INVOLVEMENT--VOLUNTARY ALCOHOL DRINKING

脑啡肽能参与——自愿饮酒

基本信息

项目摘要

The long-term objective of this research project is to determine whether endogenous enkephalins play a major role as neurotransmitters/neuromodulators of oral ethanol preference. Studies will be performed to determine whether altering the action of endogenous enkephalins changes voluntary ethanol drinking. Specifically, we will examine: 1) the extent to which various opioid receptor antagonists are capable of suppressing voluntary ethanol consumption compared with the consumption of other palatable and nonpalatable substances, 2) whether blocking endogenous opioid receptors, prior to initial exposure to ethanol, deters the initiation and development of voluntary ethanol consumption, and 3) whether increasing the duration of enkephalin action potentiates voluntary ethanol drinking. These experiments will require the use of rats which voluntarily consume large quantities of ethanol. Rats from two genetic lines, which have been bred for oral ethanol preference, will serve as subjects. We also propose to determine whether the central enkephalinergic system differs in rats that display different preferences for oral ethanol. Specifically, we will determine: 1) whether enkephalin and preproenkephalin mRNA content in discrete brain and pituitary regions differs in ethanol-naive rats which have been genetically selected for oral ethanol preference or nonpreference, 2) whether chronic voluntary ethanol drinking, and removal of ethanol following chronic consumption, alters brain and pituitary content of enkephalins and preproenkephalin mRNA, and 3) whether a true correlation exists between brain enkephalin and preproenkephalin mRNA content and the amount of ethanol voluntarily consumed during free-choice drinking. These experiments will require the use of rats which voluntarily consume high or low amounts of ethanol. Rats from four genetic lines, which have been bred for oral ethanol preference or nonpreference, will serve as subjects. The results of the proposed studies should yield additional information regarding the importance of the central enkephalinergic system in mediating the reinforcing properties of ethanol that contribute to the development and maintenance of abnormal alcohol seeking behavior which characterize human alcoholism.
这个研究项目的长期目标是确定

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

janice C Froehlich其他文献

janice C Froehlich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('janice C Froehlich', 18)}}的其他基金

When one plus one equals more than two.
当一加一大于二时。
  • 批准号:
    8851458
  • 财政年份:
    2013
  • 资助金额:
    $ 11.67万
  • 项目类别:
When one plus one equals more than two.
当一加一大于二时。
  • 批准号:
    8438107
  • 财政年份:
    2013
  • 资助金额:
    $ 11.67万
  • 项目类别:
When one plus one equals more than two.
当一加一大于二时。
  • 批准号:
    8698683
  • 财政年份:
    2013
  • 资助金额:
    $ 11.67万
  • 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
  • 批准号:
    8610862
  • 财政年份:
    2010
  • 资助金额:
    $ 11.67万
  • 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
  • 批准号:
    8036093
  • 财政年份:
    2010
  • 资助金额:
    $ 11.67万
  • 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
  • 批准号:
    8230776
  • 财政年份:
    2010
  • 资助金额:
    $ 11.67万
  • 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
  • 批准号:
    8436334
  • 财政年份:
    2010
  • 资助金额:
    $ 11.67万
  • 项目类别:
Noradrenergic Agents As Potential New Pharmacotherapies for Alcohol Drinking
去甲肾上腺素能药物作为潜在的饮酒新药物疗法
  • 批准号:
    7917969
  • 财政年份:
    2010
  • 资助金额:
    $ 11.67万
  • 项目类别:
PILOT PROJECTS
试点项目
  • 批准号:
    6712894
  • 财政年份:
    2002
  • 资助金额:
    $ 11.67万
  • 项目类别:
ALCOHOL WITHDRAWAL IN RAT LINES SELECTED FOR PREFERENCE
优先选择的大鼠系中的酒精戒断
  • 批准号:
    6948391
  • 财政年份:
    1995
  • 资助金额:
    $ 11.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了